European Union’s research policy: a moving target?
History and importance of antimalarial drug resistance
Drug resistance in Indian visceral leishmaniasis
Trypanosomiase humaine africaine: historique de la thérapeutique et de ses échecs
Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence
Biochemical and molecular mechanisms of drug resistance in parasites
Modelling parasite drug resistance: lessons for management and control strategies
Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience
Monitoring drug resistance in leishmaniasis
The phenomenon of treatment failures in Human African Trypanosomiasis
Anthelmintic resistance in human helminths: a review
Controlling malaria: challenges and solutions
A policy for leishmaniasis with respect to the prevention and control of drug resistance
Drug-based helminth control in Western Pacific countries: a general perspective
Drugs for neglected diseases: a failure of the market and a public health failure?
Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria
The access to Essential Medicines Campaign
Availability and affordability of treatment for Human African Trypanosomiasis
Pricing of drugs and donations: options for sustainable equity pricing